Taking immune system cells from the patient, genetically modifying them in the laboratory to make them “better” at recognizing and attacking the tumor, and then inject them back into the patient. Car-T therapies represent the new frontier of personalized medicine against blood cancers. Emanuele Angelucci, hematologist of the San Martino Polyclinic in Genoa, Sergio Amadori, president of AIL – Italian Association against leukemia, lymphomas, myeloma, talk about it; Deepu Madduri, hematologist researcher with Gabriele Beccaria, coordinator of the Health hub.
Health Festival. Car-T: the new frontier of oncohematology
Health Festival 2021, in Genoa to talk about medicine and hi-tech
